Sanofi Consumer Healthcare is pushing back on a recommendation that it discontinue the “#1 doctor-recommended” claim for its Zantac 360° heartburn medicine in a case brought by competitor Johnson & ...
The French pharmaceutical company Sanofi says it has reached an agreement to resolve 4,000 cases in the U.S., in which plaintiffs are linking the discontinued heartburn drug Zantac — and its active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results